Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
IPO Status: Listed [16th Jul 2021 to 20th Jul 2021]
Tatva Chintan Pharma, a chemical manufacturing company in India is coming up with an IPO of Rs. 500 Cr. The IPO opens for subscription on 16 July and closes on 20 July. The price band is fixed at Rs. 1073-1083, the floor price is 107.3 times and the cap price is 108.3 times of Rs. 10 face value. One can apply for the lot size of 13 shares and it's multiple. Stay updated to know more about Tatva Chintan Pharma IPO including business overview, financial performance, recommendations, live subscription, allotment, GMP, and more.
| IPO Issue Opening Date: | 16th Jul 2021 |
| IPO Issue Closing Date: | 20th Jul 2021 |
| IPO Issue Price: | ₹1073-1083 Per Share |
| DRHP: | Download DRHP |
| RHP: | Download RHP |
| Anchor List: | Download Anchor List |
| IPO Listing At: | BSE, NSE |
| Retail Quota: | 50 |
| IPO Issue Type: | Book Build Issue |
| IPO Issue Size: | ₹500 Cr |
| Offer for Sale: | ₹275 Cr |
| Fresh Issue: | ₹225 Cr |
| Face Value: | ₹10 Per Equity Share |
| IPO Discount: | NA |
| Promoter Holding Pre IPO: | 100% |
| Promoter Holding Post IPO: | 79.17% |
| Allotment Status: | Allotment Status |
| BSE Code: | 543321 |
| NSE Code: | TATVA |
Get important updates regarding Tatva Chintan Pharma IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
| IPO Activity | Date |
|---|---|
| Basis of Allotment Date* | 26th Jul 2021 |
| Refunds Initiation* | 27th Jul 2021 |
| Credit of Shares to Demat* | 28th Jul 2021 |
| IPO Listing Date* | 29th Jul 2021 |
* - Tentative Dates
| IPO Activity | Date |
|---|---|
| Issue Price | ₹1073-1083 |
| Market Lot: | 13 Shares |
| 1 Lot Amount: | ₹14079 |
| Min Small HNI Lots(2-10 Lakh): | 195 shares(15 lots) |
| Min Big HNI Lots(10+ Lakh): |
| GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Expected Listing Gain | Last Updated |
|---|---|---|---|---|---|
| 29-07-2021 | 1083 | 1110 | -- | ₹2193 (102.49%) | 29-Jul-2021 10:33 |
Zerodha Trade@20
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Tatva Chintan Pharma Chem Limited is one of the leading Indian manufacturers of Structure Directing Agents (SDAs) for zeolites. The company manufactures structure-directing agents, phase transfer catalysts, pharmaceutical, and agrochemical ingredients, and other specialty chemicals to meet diverse requirements of various industries i.e. automotive, agrochemicals, petroleum, paints and coatings, dyes and pigments, pharmaceutical, personal care, and others. Merck, Bayer AG, SRF Ltd, Navin Fluorine International Ltd, Atul Ltd, Divi's Laboratories, etc. are some of its prominent customers. The company sells its products in India and overseas markets such as the USA, UK, China, Germany, and South Africa.
| Incorporation | Sector | IPO Issue Size | Website |
| 1996 | Specialty Chemical | ₹500 Cr | http://www.tatvachintan.com/ |
The table below is live update of IPO bidding details from NSE and BSE.
| Day | QIB | NII | RII | Total | |
|---|---|---|---|---|---|
| # of Shares Offered | 931,966 (28.57%) | 698,975 (21.43%) | 1,630,941 (50%) | 3,261,882 | |
| 1 | 16th Jul 2021 17:03 | 0.50x | 1.14x | 8.24x | 4.51x |
| 2 | 19th Jul 2021 17:02 | 1.97x | 12.21x | 23.74x | 15.05x |
| 3 | 20th Jul 2021 17:03 | 185.23x | 512.22x | 35.35x | 180.36x |
| Tatva Chintan Pharma Chem Financials | 31-Mar-2021 | 31-Mar-2020 | 31-Mar-2019 | 31-Mar-2018 |
|---|---|---|---|---|
| Total Assets | ₹314.80 Cr | ₹248.94 Cr | ₹187.51 Cr | ₹143.72 Cr |
| Total Income | ₹306.29 Cr | ₹264.62 Cr | ₹206.80 Cr | ₹137.29 Cr |
| Net Profit/Loss | ₹52.26 Cr | ₹37.79 Cr | ₹20.54 Cr | ₹12.29 Cr |
Last Updated on 27-Sep-2021 10:40:21
